Results 191 to 200 of about 463,708 (346)

B Lymphocytes Impede Tregs to Erode Islet Tolerance in Type 1 Diabetes. [PDF]

Diabetes
Wilson CS, Stocks BT, Falk AC, Moore DJ.
europepmc   +1 more source

Experimental Infection withTrypanosoma cruziIncreases the Population of CD8⁺, but not CD4⁺, Immunoglobulin G Fc Receptor-Positive T Lymphocytes

, 2005
Andrea Henriques‐Pons, Bianca Olivieri, Gabriel Melo de Oliveira, Marc Daëron, Tânia Cremonini de Araújo-Jorge   +4 more
openalex   +1 more source

NIR‐Activatable Domino Cascade Catalysis Nanozyme Reactor for Multi‐Mechanism Synergistic Immunotherapy in Bladder Cancer

Advanced Science, EarlyView.
This study presents an intravesical delivery strategy of ferroptosis‐ and immunity‐inducing nanozyme‐loaded thermoresponsive hydrogels (FMCC@PNH) for enhanced bladder cancer therapy. Abstract Current intravesical therapies for bladder cancer after resection are limited by poor tissue penetration, off‐target effects, and insufficient efficacy.
Yongnan Jiang, Qingling Zhang, Yuhan Zhang, Xinlu Yu, Bo Jia, Yulong Dong, Yalong Wu, Kelong Fan, Xinquan Gu, Lei Ji, Wei Jiang, Bin Liu   +11 more
wiley   +1 more source

Efficacy and safety of SMET12 in combination with toripalimab and chemotherapy in advanced non-small-cell lung cancer patients tested positive for EGFR protein who are treatment-naïve or harbor acquired resistance to standard therapy: a phase 2, multi-cohort clinical trial. [PDF]

Front Immunol
Lin J, Chen S, Li M, Weng L, Xu H, Wang Q, Zhang J, Lin D, Wang H, Liu Q, He Z.   +10 more
europepmc   +1 more source

Population‐Based Multi‐Omics and Cohort Study Identifying Predictive Biomarkers and Therapeutic Targets for Psoriatic Disease

Advanced Science, EarlyView.
Psoriatic disease (PsD) is a chronic skin disease, with challenges in early risk stratification and drug development. Through gene‐level causal inference framework and expression level validation, combined with longitudinal cohort study, CDSN and PRSS8 have been identified as candidate biomarkers and therapeutic targets for PsD.
Tianxing Wu, Jialiang Luo, Haoyuan Qiu, Weijie Shao, Yueyang Lu, Meixuan Luo, Zhaofeng Lin, Yan Zhang, Libo Zhang, Hong Wang, Jia Zhou, Guangfeng Ruan, Peihua Cao, Daming Zuo   +13 more
wiley   +1 more source

Intraperitoneal immune microenvironment and efficacy of intraperitoneal chemotherapy in patients with gastric cancer and peritoneal metastasis. [PDF]

Sci Rep
Nakanishi T, Imano M, Kohda M, Kato H, Kounami N, Yamada A, Terada M, Hiraki Y, Shiraishi O, Yasuda A, Shinkai M, Yasuda T.   +11 more
europepmc   +1 more source

Age‐dependent variation in the proportion and number of intestinal lymphocyte subsets, especially natural killer T cells, double‐positive CD4⁺ CD8⁺ cells and B220⁺ T cells, in mice

, 2004
Yuiko Ishimoto, Chikako Tomiyama‐Miyaji, Hisami Watanabe, Hisashi Yokoyama, Kazuto Ebe, Shunsuke Tsubata, Yutaka Aoyagi, Toru Abo   +7 more
openalex   +1 more source

Distribution of porcine CD4/CD8 double‐positive T lymphocytes in mucosa‐associated lymphoid tissues

Immunology, 1996
F. Zuckermann, H. Gaskins
semanticscholar   +1 more source

Mutual Exclusion Analysis Shows that DUSP9 Negatively Regulates PD‐L1 Expression and Acts as a Target to Enhance Anti‐PD‐1 Efficacy

Advanced Science, EarlyView.
A mutually exclusive screening system is established to identify negative regulators of highly plastic genes. Dual specificity phosphatase (DUSP9) is a novel negative regulatory molecule of PD‐L1 by dephosphorylating STAT3, and acts as a target molecule in combination with PD‐1 antibody for tumor immunotherapy and a new clinical biomarker for ...
Yuzhe Hu, Ling Tang, Zheng Kuang, Danyi Huang, Ting Li, Gaofei Yin, Yingyu Chen, Wei Guo, Wenling Han, Pingzhang Wang   +9 more
wiley   +1 more source

Tumor Infiltrating Lymphocytes in Cutaneous Squamous Cell Carcinoma-A Systematic Review. [PDF]

Dermatopathology (Basel)
Loo LY, Tay SH, Oh CC.
europepmc   +1 more source